|
| Press Releases |
|
 |
|
| Friday, February 10, 2023 |
|
|
First Patient in the US Dosed in a Global Multicentre Phase 3 Clinical Study of Bevacizumab for treatment of Ophthalmic Diseases |
| Essex Bio-Technology Ltd ("Essex" or the "Group", Stock Code: 1061.HK) today announced that the first patient in the United States (US) was dosed in a global multi-centre phase 3 clinical trial (NCT04740671) of EB12-20145P (HLX04-O), a recombinant anti-VEGF humanised monoclonal antibody injection jointly developed by the Group and Shanghai Henlius Biotech, Inc. more info >> |
|
| Thursday, October 13, 2022 |
|
|
Essex Biotechnology Secures Exclusive Rights and Interests in SkQ1 for Ophthalmology from Mitotech |
| Essex Bio-Technology Ltd (Essex Bio-Technology; HKG: 1061) wishes to announce that wholly-owned subsidiary Essex Bio-Investment Ltd (Essex Bioinvestment) on 13 October 2022 successfully secured (i) a patent and know-how licence agreement; and (ii) a patent assignment deed in relation to SkQ1, an active pharmaceutical ingredient, from Mitotech S.A. more info >> |
|
| Tuesday, August 16, 2022 |
|
|
Essex Bio-Technology Included in "Forbes Asia's Best Under A Billion 2022" |
| Essex Bio-Technology Ltd ("EssexBio" or the "Group", Stock Code: 1061.HK) is pleased and honoured to announce that it is included in "Forbes Asia's 200 Best Under A Billion 2022" - for the Group's outstanding long-term sustainable development across a variety of metrics. more info >> |
|
| Tuesday, March 22, 2022 |
|
|
Essex Bio-Technology Announces 2021 Financial Results |
| Essex Bio-Technology Ltd ("Essex" or the "Group", Stock Code: 1061.HK) today announced the annual results for the year ended 31 December 2021. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Eisai and Merck & Co., Inc., Rahway, NJ, USA Provide Update on Phase 3 LEAP012 Trial in Unresectable, Non-Metastatic Hepatocellular Carcinoma
Oct 29, 2025 0:53 JST
|
|
|
Mazda Presents World Premiere of Two Vision Models at Japan Mobility Show 2025
Oct 29, 2025 0:33 JST
|
|
|
Mazda Rolls Out New Version of Brand Symbol from Japan Mobility Show 2025
Oct 29, 2025 0:26 JST
|
|
|
NEC and the Cambodian Mine Action Center Successfully Predict Landmine-Contaminated Areas in Cambodia Using AI
Oct 29, 2025 0:18 JST
|
|
|
Overview of Honda CEO Speech at the Japan Mobility Show 2025
Oct 29, 2025 0:00 JST
|
|
|
Honda Presents World Premiere of the Prototype of Honda 0 a, new SUV Model for Honda 0 Series at Japan Mobility Show 2025
Oct 29, 2025 23:55 JST
|
|
|
Honda Presents World Premiere of Super-ONE Prototype Compact EV at Japan Mobility Show 2025
Oct 29, 2025 23:50 JST
|
|
|
Mitsubishi Motors Debuts Mitsubishi Elevance Concept and Adventure-Inspiring Lineup at Japan Mobility Show 2025
Oct 29, 2025 23:39 JST
|
|
|
Fujitsu and PwC Japan partner on economic security measures for sovereign cloud solution
Oct 29, 2025 23:22 JST
|
|
|
Hitachi Rail becomes world's first transportation firm to adopt new NVIDIA IGX Thor solution for real-time AI
Oct 29, 2025 23:00 JST
|
|
|
Ecological Threat Report 2025: Extreme Wet-Dry Seasons Emerge as Critical Conflict Catalyst
Oct 29, 2025 13:00 HKT/SGT
|
|
|
Reclaims Global Positions for Next Phase of Growth with Successful Placement and Strong Sector Momentum
Oct 29, 2025 11:14 HKT/SGT
|
|
|
GTJAI Assisted Deepexi Technology in Successfully Listing on the Main Board of the Hong Kong Stock Exchange
Oct 29, 2025 10:30 HKT/SGT
|
|
|
GTJAI Serves as the Sole Sponsor for CIG, Achieving the Largest IPO in the Telecommunications Equipment Sector across Both A-shares and H-shares Markets
Oct 29, 2025 10:27 HKT/SGT
|
|
|
Olympus Introduces NBI+TXI(TM) Observation Mode to the EVIS X1(TM) Endoscopy System CV-1500 Video System Center 
Oct 29, 2025 11:00 JST
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
